US Stock MarketDetailed Quotes

RCEL Avita Medical

Watchlist
  • 10.570
  • +1.790+20.39%
Close Feb 14 16:00 ET
  • 10.400
  • -0.170-1.61%
Post 20:01 ET
278.60MMarket Cap-4.42P/E (TTM)

Avita Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avita Medical Q4 2024 Earnings Date

Currency：USDFeb 13, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
19.65M
18.41M
-1.25M
Miss Est.
+33.02%
+29.67%
-6.35%
EPS
-0.48
-0.44
+0.04
Beat Est.
-63.51%
-57.14%
+7.62%
Analyst Rating
Buy

Feb 14, 2025

Avita Medical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 36.673M--
--2025/Q1-- / 32.486M--
Feb 13, 20252024/Q429.212M / 31.590M--
Nov 7, 20242024/Q329.311M / 29.222M--
Aug 8, 20242024/Q223.124M / 21.981M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 36.673M--
--2025/Q1-- / 32.486M--
Feb 13, 20252024/Q429.212M / 31.590M--
Nov 7, 20242024/Q329.311M / 29.222M--
Aug 8, 20242024/Q223.124M / 21.981M--

Unlock Free Earnings Estimates

Avita Medical Earnings Reports

  • 10-K: FY2024 Annual Report

    Feb 13 17:14 ET

  • 8-K: AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results

    Feb 13 16:11 ET

  • 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:18 ET

  • 8-K: AVITA Medical Reports Third Quarter Financial Results

    Nov 7, 2024 16:08 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +17.56%
    DexCom
    DXCM
    +5.92%
    Hutchmed (China)
    HCM
    +4.39%
    New Fortress Energy
    NFE
    +2.70%
    Enerpac Tool
    EPAC
    +1.85%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 14, 2025

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-1.46%